<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Regdanvimab Feed]]></title>
        <description><![CDATA[Regdanvimab articles]]></description>
        <link>https://sps.devopsroom.com</link>
        <generator>sps.ro</generator>
        <lastBuildDate>Wed, 17 Jun 2026 16:37:32 GMT</lastBuildDate>
        <atom:link href="https://sps.devopsroom.com/tag/regdanvimab/feed" rel="self" type="application/rss+xml"/>
        <pubDate>Wed, 17 Jun 2026 16:37:32 GMT</pubDate>
        <language><![CDATA[ro-RO]]></language>
        <item>
            <title><![CDATA[După ce a aprobat și doza a treia, EMA evaluează un tratament anti-COVID-19 miraculos]]></title>
            <description><![CDATA[Agenţia Europeană pentru Medicamente (EMA) a început luni evaluarea în vederea autorizării tratamentului cu anticorpi monoclonali Regkirona (Regdanvimab) pentru pacienţii cu COVID-19 dezvoltat de compania farmaceutică sud-coreeană Celltrion, relateaz...]]></description>
            <link>https://sps.devopsroom.com/dupa-ce-a-aprobat-si-doza-a-treia-ema-evalueaza-un-tratament-anti-covid-19-miraculos_2030869.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/dupa-ce-a-aprobat-si-doza-a-treia-ema-evalueaza-un-tratament-anti-covid-19-miraculos_2030869.html</guid>
            <category><![CDATA[Marea Britanie]]></category>
            <category><![CDATA[SUA]]></category>
            <category><![CDATA[israel]]></category>
            <category><![CDATA[virus]]></category>
            <category><![CDATA[vaccinuri]]></category>
            <category><![CDATA[Johnson & Johnson]]></category>
            <category><![CDATA[ECDC]]></category>
            <category><![CDATA[EMA]]></category>
            <category><![CDATA[astrazeneca]]></category>
            <category><![CDATA[COVID-19]]></category>
            <category><![CDATA[coronvirus]]></category>
            <category><![CDATA[lockdown]]></category>
            <category><![CDATA[Pfizer/BioNTech]]></category>
            <category><![CDATA[Janssen]]></category>
            <category><![CDATA[CHMP]]></category>
            <category><![CDATA[Regdanvimab]]></category>
            <category><![CDATA[varianta delta]]></category>
            <category><![CDATA[Regkirona]]></category>
            <category><![CDATA[Celltrion]]></category>
            <category><![CDATA[Celltrion Healthcare Hungary Kft]]></category>
            <category><![CDATA[Știrile Zilei]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <category><![CDATA[Tarom AirFi]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Tue, 05 Oct 2021 16:20:03 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202107/1600x900/media-162566147668523900.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[Agenția Europeană a Medicamentului testează un nou tratament împotriva Covid-19: Regdanvimab a dat rezultate promițătoare]]></title>
            <description><![CDATA[Agenţia Europeană pentru Medicamente (EMA) a început miercuri analizarea în timp real a datelor privind Regdanvimab, un medicament pentru tratarea COVID-19 cu anticorpi monoclonali, dezvoltat de compania farmaceutică sud-coreeană Celltrion, relatează...]]></description>
            <link>https://sps.devopsroom.com/agentia-europeana-a-medicamentului-testeaza-un-nou-tratament-impotriva-covid-19-regdanvimab-a-dat-rezultate-promitatoare_1663360.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/agentia-europeana-a-medicamentului-testeaza-un-nou-tratament-impotriva-covid-19-regdanvimab-a-dat-rezultate-promitatoare_1663360.html</guid>
            <category><![CDATA[Agenția Europeană a Medicamentului]]></category>
            <category><![CDATA[COVID 19]]></category>
            <category><![CDATA[Regdanvimab]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Uniunea Europeană]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <dc:creator><![CDATA[Florin Pușcaș]]></dc:creator>
            <pubDate>Thu, 25 Feb 2021 13:27:55 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202102/1600x900/media-161423772308607100.webp" length="0" type="image/webp"/>
        </item>
    </channel>
</rss>